Feasibility of a “Salvage Regimen” Using Home-based Intravenous Meropenem Therapy With a Delamanid/Bedaquilline Containing Regimen in the Management of MDR/XDR Pediatric Tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility of a “Salvage Regimen” Using Home-based Intravenous Meropenem Therapy With a Delamanid/Bedaquilline Containing Regimen in the Management of MDR/XDR Pediatric Tuberculosis

Published:2022-02-10 Issue:5 Volume:41 Page:401-404
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Shah Ira,Antony Sonu,Jaiswal Akanksha,Bodhanwala Minnie,Shah Daksha,Tipre Pranita,Salve Jyoti,Parmar Malik,Sachdeva K. S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference9 articles.

1. Increasing prevalence of pediatric drug-resistant tuberculosis in Mumbai, India, and its outcome.;Shah;Pediatr Infect Dis J,2018

2. Salvage therapy for multidrug-resistant tuberculosis.;Seung;Clin Microbiol Infect,2014

3. Early efficacy and safety of Bedaquiline and Delamanid given together in a “Salvage Regimen” for treatment of drug-resistant tuberculosis.;Sarin;Indian J Tuberc,2019

4. Effectiveness and safety of imipenem/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil.;Arbex;Rev Port Pneumol (2006),2016

5. Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis.;Payen;Int J Tuberc Lung Dis,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Side effects of drugs used in the treatment of tuberculosis and leprosy;Side Effects of Drugs Annual;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP